Built for Precision Oncology
Our products are designed to accelerate your cancer research and drug development.
OncoExo™
Unlocking the Power of Tumor Exosomes
Tumor-derived exosomes are transforming our understanding of cancer biology — from reshaping the tumor microenvironment to mediating long-range communication and enabling smarter therapeutic interventions.
OncoExo™ stands at the forefront of this revolution, offering researchers and innovators access to high-purity, high-quality tumor exosomes that meet the rigorous demands of next-generation biomedical research.
With OncoExo™, you gain more than just a product — you gain a partner in precision oncology, committed to accelerating discovery, enhancing data reliability, and empowering the future of personalized medicine.
OncoReveal™
Illuminate Tumors with Precision
OncoReveal™ is a novel tumor-tracing technology utilizing carbon quantum dots (CQDs) specifically designed to accumulate in PDX tumor models without affecting tumor growth. It offers a highly sensitive, non-toxic, and non-invasive imaging solution for monitoring tumor progression and metastasis.
Key Applications of Products
- Precision Cancer Diagnosis – Utilize exosomal biomarkers for early cancer detection, enhancing diagnostic accuracy.
- Disease Progression Monitoring – Track tumor evolution in real time through exosome molecular analysis, providing scientific insights for precision treatment.
- Personalized Treatment Support – Analyze patient-specific exosome profiles to assist in targeted drug development and treatment evaluation.
- Innovative Drug Delivery Platform – Leverage exosomes as a natural drug carrier to improve delivery efficiency, enhance targeting, and ensure biocompatibility.
- Immunoregulation Research – Investigate immune evasion mechanisms and explore exosome applications in cancer immunotherapy.
